Interim Measure Offers Clarity On E-Labeling In Canada
Executive Summary
While the Canadian regulator finalizes its policy on using electronic labeling, it has issued an interim order that explains what information companies can include in electronic platforms that are linked to a drug’s physical label.
You may also be interested in...
Canada Consults On Electronic Labels To Supplement Prescription Drug Info
Health Canada has noted a growing interest among companies to incorporate in their product labels a link to websites/apps to offer additional information about prescription drugs. These electronic platforms are regulated as electronic labels and must be approved prior to distribution.
EMA To Update Active Substances Guide To Address Nitrosamine Contamination
The European Medicines Agency wants to make it clearer for drug sponsors what more they can do to address the presence of cancer-causing impurities in active substances, and how to deal with the issue in their regulatory submissions.
EMA Tackles Delays With Scientific Advice Procedure
A surge in scientific advice requests in the latter half of 2021 forced the European Medicines Agency to delay the start of some procedures, but the situation has improved considerably since then.